Basic information
- Name:
1,2,4-Oxadiazole-5-ethanamine,N,N-diethyl-3-phenyl-, hydrochloride (1:1)
- CAS No.:
1219-20-1
- Molecular Structure:
- Formula:
- C14H19 N3 O . Cl H
- Molecular Weight:
- 281.82
- Synonyms:
- 1,2,4-Oxadiazole,5-[2-(diethylamino)ethyl]-3-phenyl-, monohydrochloride (8CI);1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-phenyl-, monohydrochloride (9CI);Oxolamine hydrochloride
- Hazard Symbols:
- 3
- Safety Description:
- Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion and subcutaneous routes. When heated to decomposition it emits toxic fumes of NOx and HCl. See also AMINES and OXOLAMINE; OXOLAMINE CITRATE. Details
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Chemistry
IUPAC Name: Diethyl-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]azanium chloride
Synonyms of Oxolamine hydrochloride (CAS NO.1219-20-1): Diethyl-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]azanium chloride ; 5-(2-(Diethylamino)ethyl)-3-phenyl-1,2,4-oxadiazole hydrochloride ; 5-(2-Dietilaminoetil)-3-fenil-1,2,4-oxadiezolo cloridrato ; Oxolamina cloridrato ; Oxolamine HCl ;(Diethyl)(3-phenyl-1,2,4-oxadiazole-5-ethyl)ammonium chloride ; 1,2,4-Oxadiazole, 5-(2-(diethylamino)ethyl)-3-phenyl-, monohydrochloride
CAS NO: 1219-20-1
Molecular Formula: C14H20ClN3O
Molecular Weight: 281.7811
Molecular Structure : .png)
EINECS: 214-940-6
H bond acceptors: 4
H bond donors: 0
Freely Rotating Bonds: 6
Polar Surface Area: 38.92 Å2
Flash Point: 174.4 °C
Enthalpy of Vaporization: 61.1 kJ/mol
Boiling Point: 364.8 °C at 760 mmHg
Vapour Pressure: 1.64E-05 mmHg at 25°C
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 208mg/kg (208mg/kg) | British Journal of Pharmacology and Chemotherapy. Vol. 16, Pg. 209, 1961. | |
| mouse | LD50 | intravenous | 63mg/kg (63mg/kg) | British Journal of Pharmacology and Chemotherapy. Vol. 16, Pg. 209, 1961. | |
| mouse | LD50 | oral | 1061mg/kg (1061mg/kg) | Bollettino Chimico Farmaceutico. Vol. 109, Pg. 476, 1970. | |
| mouse | LD50 | subcutaneous | 465mg/kg (465mg/kg) | British Journal of Pharmacology and Chemotherapy. Vol. 16, Pg. 209, 1961. | |
| rat | LD50 | intraperitoneal | 185mg/kg (185mg/kg) | British Journal of Pharmacology and Chemotherapy. Vol. 16, Pg. 209, 1961. | |
| rat | LD50 | intravenous | 63mg/kg (63mg/kg) | French Medicament Patent Document. Vol. #683M, | |
| rat | LD50 | oral | 1650mg/kg (1650mg/kg) | British Journal of Pharmacology and Chemotherapy. Vol. 16, Pg. 209, 1961. | |
| rat | LD50 | subcutaneous | 465mg/kg (465mg/kg) | French Medicament Patent Document. Vol. #683M, |
Safety Profile
Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion and subcutaneous routes. When Oxolamine hydrochloride (CAS NO.1219-20-1) is heated to decomposition, it emits toxic fumes of NOx and HCl. See also AMINES and OXOLAMINE; OXOLAMINE CITRATE.